Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Genet Mol Res ; 13(3): 8025-34, 2014 Sep 29.
Article in English | MEDLINE | ID: mdl-25299117

ABSTRACT

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide. In Egypt, the incidence of HCC has doubled over the last decade. Matrix metalloproteinase-9 (MMP-9) plays a key role in cancer invasion and metastasis by degrading the extracellular matrix and basement membrane barriers. A cytosine (C)/thymidine (T) single nucleotide polymorphism at position -1562 in the MMP-9 promoter is reported to influence the expression of the MMP-9 gene. The association between MMP-9 gene polymorphisms and HCC patients with hepatitis C and B viruses (HCV and HBV) was examined in 91 patients with HCC and viral hepatitis (55 HCV and 36 HBV). The results were compared with those of 42 HCC patients without viral hepatitis and 60 healthy individuals with no liver infection. Polymorphisms of the MMP-9 gene were investigated by polymerase chain reaction amplification followed by restriction fragment length polymorphism analysis. The serum MMP-9 level was quantitatively determined using a human MMP-9 enzyme-linked immunosorbent assay, which showed that homozygosity of the MMP-9 promoter (TT) was more frequent in patients with HCC and chronic HCV or HBV infection when compared with the control group (49.1, 52.8, and 35.7%, respectively). In addition, we observed significant elevation of serum MMP-9 levels in all HCC groups compared to controls. It was concluded that patients with the MMP-9 TT genotype are at risk of developing HCC and HBV or HCV. People with significantly elevated serum levels of MMP-9 are at risk of developing HCC.


Subject(s)
Carcinoma, Hepatocellular/enzymology , Hepatitis B/enzymology , Hepatitis C/enzymology , Liver Neoplasms/enzymology , Matrix Metalloproteinase 9/genetics , Polymorphism, Genetic , Base Sequence , Carcinoma, Hepatocellular/etiology , Case-Control Studies , DNA Primers , Hepatitis B/complications , Hepatitis C/complications , Humans , Liver Neoplasms/complications , Matrix Metalloproteinase 9/blood , Promoter Regions, Genetic , Reverse Transcriptase Polymerase Chain Reaction
2.
J Egypt Soc Parasitol ; 43(1): 275-86, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23697033

ABSTRACT

Fascioliasis is an important food- and water-borne parasitic zoonosis caused by liver flukes of genus Fasciola (Digenea: Fasciolidae) of worldwide distribution. In Egypt, fascioliasis was encountered in nearly all Egyptian Governorates, particularly in the Nile Delta and specifically in Dakahlia. All enrolled cases were subjected to complete history taking, clinical examination, routine investigations and abdominal ultrasonography. Stool analysis, IHA and ELISA were used for fascioliasis diagnosis. Rural areas showed highest prevalence of fascioliasis than urban areas, however, but.without significance (x2= 0.042 & P= 0.837). Regarding human fascioliasis in examined the centers, no statistically significant difference (x2 =2.824 & P=0.243) was detected. Regarding gender variation, the difference was statistically insignificant (x2= 0.166 & P= 0.683). The difference between the age groups was statistically insignificant (x2= 3.882 & P=0.274). Clinically, 7 cases (35%) were asymptomatic and another 13 cases (65%) had different clinical pictures. Abdominal pain, anemia, eosinophilia, and tender hepatomegaly were seen in 70%, 80%, 70%, and 10%; respectively. Of them, 1 1cases showed positive abdominal ultrasonographic findings suggestive of fascioliasis.


Subject(s)
Fascioliasis/epidemiology , Adolescent , Adult , Child , Child, Preschool , Egypt/epidemiology , Fascioliasis/diagnosis , Fascioliasis/pathology , Feces/parasitology , Female , Humans , Male , Parasite Egg Count , Prevalence , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...